Clinical Trials Sponsored by RTI health solutions, US
Total 17 results
-
Boehringer IngelheimRTI health solutions, USCompletedPulmonary Disease, Chronic ObstructiveDenmark, France, Netherlands
-
BayerRTI Health SolutionsCompletedProstatic NeoplasmsUnited States
-
AstraZenecaRTI Health SolutionsCompletedPulmonary Disease, Chronic ObstructiveDenmark, Germany, United Kingdom
-
BayerRTI Health SolutionsCompletedMacular DegenerationFrance, Germany, Spain, Italy, United Kingdom
-
BayerRTI Health SolutionsCompleted
-
GlaxoSmithKlineRTI Health SolutionsCompletedLung Cancer, Non-Small Cell
-
GlaxoSmithKlineRTI Health Solutions(RTI HS)Completed
-
AstraZenecaRTI Health SolutionsRecruitingPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
AstraZenecaRTI Health SolutionsCompletedCOVID-19, Vaccine Adverse Events of Special InterestNetherlands, Spain, United Kingdom
-
BayerRTI Health SolutionsCompletedAcne VulgarisFrance, Spain, Austria, Czech Republic, Netherlands
-
Tioga PharmaceuticalsRTI Health SolutionsCompletedDiarrhea Predominant Irritable Bowel SyndromeUnited States
-
Tioga PharmaceuticalsRTI Health SolutionsTerminated
-
Tioga PharmaceuticalsRTI Health SolutionsCompletedIrritable Bowel SyndromeUnited States
-
PfizerOptum, Inc.; RTI Health SolutionsRecruiting
-
BayerJanssen Research & Development, LLC; RTI Health SolutionsCompletedAnticoagulationGermany, United Kingdom, France, Spain
-
TakedaRTI Health Solutions; Baxalta Innovations GmbH, now part of ShireCompletedChronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)United States
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia